Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.580
-0.010 (-1.69%)
At close: Jan 31, 2025, 4:00 PM
0.570
-0.010 (-1.72%)
After-hours: Jan 31, 2025, 7:58 PM EST
MTNB Employees
Matinas BioPharma Holdings had 32 employees as of December 31, 2023. The number of employees decreased by 2 or -5.88% compared to the previous year.
Employees
32
Change (1Y)
-2
Growth (1Y)
-5.88%
Revenue / Employee
n/a
Profits / Employee
-$660,375
Market Cap
2.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MTNB News
- 22 days ago - Matinas BioPharma Receives NYSE Noncompliance Notice - GlobeNewsWire
- 3 months ago - Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - GlobeNewsWire
- 6 months ago - Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 6 months ago - Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024 - GlobeNewsWire
- 7 months ago - Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program - GlobeNewsWire
- 8 months ago - Matinas BioPharma's Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. - GlobeNewsWire
- 9 months ago - New In Vitro Data Showing Matinas BioPharma's LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 - GlobeNewsWire